Upon activation, CXCR2 internalizes very rapidly relative to CXCR1 (~90% vs ~10%, respectively, after 5 min). The carboxyl-terminus of the receptors were shown to be necessary for internalization but are not sufficient to explain the distinct kinetics of downregulation. Chemokines are a family of structurally related peptides that regulate inflammation through cell surface G-protein coupled receptors (GPCRs) on leukocytes. These peptides mediate diverse biological and biochemical activities including adhesion to endothelium, directed migration, and activation of cytotoxic activities such as the respiratory burst and exocytosis (1,2). Chemokines have been classified into four families; C, CC, CXC, and CX3C based on the number and positions of the N-terminal-conserved cysteine residues. Most chemokines activate more than one chemokine receptor and many chemokine receptors are activated by multiple chemokines (3). CXCL8 activates two receptors, CXCR1 and CXCR2. CXCR1 is specific for CXCL8 whereas CXCR2 also interacts with CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7(4). (5, 6) . Like many GPCRs, both receptors become phosphorylated, desensitized and internalized upon exposure to CXCL8. Over 95% of CXCR2 internalizes in the first 2-5 min of activation as compared to ~10% of CXCR1 (7-10). CXCR2 also recovers more slowly (~35% after 90 min) to the cell surface than CXCR1 (~100% after 90 min) upon removal of CXCL8 (7, 8, (11) (12) (13) (14) . This difference in receptor trafficking appears to be an important factor in the distinct ability of CXCR1 and CXCR2 to mediate leukocyte activation and regulation in response to CXCL8 (9,10).
Interleukin-8 (IL-8 or CXCL8) interacts with two receptors CXCR1 and CXCR2 to activate leukocytes.
Upon activation, CXCR2 internalizes very rapidly relative to CXCR1 (~90% vs ~10%, respectively, after 5 min). The carboxyl-terminus of the receptors were shown to be necessary for internalization but are not sufficient to explain the distinct kinetics of downregulation. To determine the structural determinant(s) that modulate receptor internalization, various chimeric and point mutant receptors were generated by progressively exchanging specific domains or amino acids between CXCR1 and CXCR2. The receptors were stably expressed in RBL-2H3 cells and characterized for receptor binding, intracellular Ca Chemokines are a family of structurally related peptides that regulate inflammation through cell surface G-protein coupled receptors (GPCRs) on leukocytes. These peptides mediate diverse biological and biochemical activities including adhesion to endothelium, directed migration, and activation of cytotoxic activities such as the respiratory burst and exocytosis (1, 2) . Chemokines have been classified into four families; C, CC, CXC, and CX3C based on the number and positions of the N-terminal-conserved cysteine residues. Most chemokines activate more than one chemokine receptor and many chemokine receptors are activated by multiple chemokines (3) . CXCL8 activates two receptors, CXCR1 and CXCR2. CXCR1 is specific for CXCL8 whereas CXCR2 also interacts with CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 (4) . Upon activation, both receptors couple to pertussis toxin (Ptx)-sensitive G protein to mediate phosphoinositide (PI) hydrolysis, intracellular Ca 2+ mobilization, chemotaxis, and exocytosis. CXCR1, but not CXCR2, activates phospholipase D (PLD) and mediates respiratory burst, suggesting that the two receptors may play different physiological roles (5, 6) . Like many GPCRs, both receptors become phosphorylated, desensitized and internalized upon exposure to CXCL8. Over 95% of CXCR2 internalizes in the first 2-5 min of activation as compared to ~10% of CXCR1 (7) (8) (9) (10) . CXCR2 also recovers more slowly (~35% after 90 min) to the cell surface than CXCR1 (~100% after 90 min) upon removal of CXCL8 (7, 8, (11) (12) (13) (14) . This difference in receptor trafficking appears to be an important factor in the distinct ability of CXCR1 and CXCR2 to mediate leukocyte activation and regulation in response to CXCL8 (9, 10) .
To date, the molecular basis for the differential regulation of the CXCL8 receptors remains unclear. CXCR1 and CXCR2 are highly homologous (77%) (15, 16) . The most divergent regions are the amino terminus (N-terminus), the fourth transmembrane domain (TMD), the second extracellular loop (ECL), and the carboxyl terminal (C-terminal) (15) (16) (17) (18) . While both receptors internalize via a phosphorylation/arrestin/dynamin-dependent mechanism, CXCR2 was also shown to internalize via a phosphorylation-independent mechanism (19) . This partial internalization of the receptors requires the interaction of the C-terminal dileucine motif LLKIL with scaffold proteins such as adaptor protein-2 (AP-2) (20) .
Previous studies using phosphorylation-deficient and C-terminal deletion mutants of CXCR1 and CXCR2 indicate that the cytoplasmic tails of the receptors are necessary for receptor phosphorylation and subsequent arrestin binding but not sufficient to account for the differences in receptor internalization and recycling (10) . Recent studies in our laboratory and others (8, 10, 13, 14, 21, 22) also demonstrated that chimeric receptors in which the C-terminal of CXCR1 was exchanged for that of CXCR2, and vice versa, mediated cellular responses and internalized as well as the wild-type (WT) receptors. This suggests that domains other than the C-terminals modulate the rates of CXCR1 and CXCR2 trafficking in response to CXCL8.
In the present work, we sought to determine the structural determinants of CXCR2 involved in rapid receptor internalization relative to CXCR1. To that end, chimeric and point mutant receptors exchanging different regions or specific amino acids of CXCR2 for their CXCR1 counterparts were generated and expressed in RBL-2H3 cells. The receptors were characterized for their pharmacological and physiological properties as well as their ability to undergo receptor internalization, phosphorylation and desensitization in response to CXCL8 occupancy. The data herein indicate that the 2ECL of the CXCR2 is critical for its rapid internalization relative to CXCR1. Point mutants and computational modeling studies further identified Asp199 of the 2ECL as a key modulator of CXCR2 rapid internalization.
MATERIALS AND METHODS

Materials:
[ To facilitate the interpretation of the data, A and B were also employed throughout this manuscript to designate the chimeric and point mutant receptors. The chimeras were excised from pCEP4 using NotI and XhoI and subcloned into the expression vector pcDNA3.
Construction of chimeric and point mutants of CXCR1 and CXCR2. The CXCR1 and CXCR2 cDNAs possess a unique conserved BamHI restriction site located at the junction of the second extracellular loop (2ECL) and transmembrane domain 5 (TMD5). This site is also conserved in chimeric mutants ABA and BAB and was used to generate the chimeric receptors (17) . A 4TMD B and BB 4TMD A were generated by polymerase chain reaction (PCR) using ABA and BAB as templates, T7 pcDNA3 as forward primer and two reverse primers corresponding to the 2ECL of CXCR1 (A2ECL):  5′ GGGCAGGATCCGTAACACCATCCGCCATT  TTGCTGTGTCGTTGCCCAGGACCTCATAGC  AAACTGGGCTGGAATTGTTTGGATGGACGG  TCCTTCG 3′,  and CXCR2 (B2ECL):  5′AGGCAGGATCCGCAACAGCATCCGCCAGT  TTGCTGTATTATTTCCCATGTCCTCATAGCA  GGCTGGACTAACATTGGATGAGTAGTAAGC  CTGGCG 3′ . The Bam H1 site is depicted by underlined sequences. For the generation of A 2ECL B and B 2ECL A, the same reverse primers were employed using CXCR1 (B2ECL) and CXCR2 (A2ECL) as templates, respectively. The resulting PCR products were digested with Not I and BamHI and ligated into pcDNA3-CXCR1 (A 4TMD B & A 2ECL B) or pcDNA3-CXCR2 (B 4TMD A & B 2ECL A) digested with the same restriction enzymes. Point mutations were introduced into pcDNA3-CXCR1 or pcDNA3-CXCR2 constructs using the QuickChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. Forward and reverse primers were designed with single base changes to incorporate amino acid point mutations. The identity of all chimeric and point mutant constructs and fidelity of all PCR based coding sequences were verified by sequencing.
Cell culture and transfection: RBL-2H3 cells were maintained as monolayer cultures in Dulbacco's modified Eagle's medium (DMEM) supplemented with 15% heat inactivated fetal bovine serum, 2 mM glutamine, penicillin (100 units/ml), and streptomycin (100 mg/ml) (24 (24, 26) . For calcium mobilization, cells (5x10 6 ) were washed with HEPES buffered saline and loaded with 1 μM Indo I-AM in the presence of 1 μM pluronic acid for 30 minutes at room temperature. The cells were then washed with HEPES and resuspended in 1.5 ml of Siriganian buffer. Intracellular calcium increase in the presence or absence of ligands was measured as described previously (27) .
Phosphorylation of receptors:
Phosphorylation of receptors was performed as described previously (10, 25, 28) . RBL-2H3 cells (5x10 6 ) expressing the receptors were incubated with [ 32 P]orthophosphate (150 μCi/dish) for 90 min. The labeled cells were then stimulated with the indicated ligands for 5 minutes at 37 o C. Cells were then washed with icecold PBS and solubilized in 1 ml of radioimmunoassays buffer (RIPA) containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS. Cell lysates were immunoprecipitated with specific antibodies against either the N-terminus of CXCR1 or CXCR2 and analyzed by SDS electrophoresis and visualized by autoradiography.
Extracellular regulated kinase (ERK) activity.
For ERK activity, RBL-2H3 cells (5x10 6 ) expressing the receptors were washed three times with PBS, then resuspended in PBS containing CXCL8 (100 nM) for different periods of time at 37 o C. The reactions were stopped with ice-cold PBS, cells were collected by centrifugation and membranes were prepared and assayed for protein concentration as described previously (28) . Membrane proteins (~50μg) were resolved in 10% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with antibodies against either ERK 1/2 or phospho-ERK 1/2 (28). Detection was carried out with HRP-conjugated sheep anti-mouse antibody and ECL.
Homology modeling of human CXCR2. Multiple sequence alignment of the rhodopsin and human CXCR2, along with human CXCR1, was performed by CLUSTALW (http://align.genome.jp) using the BLOSUM matrix. To prohibit any gap within the TMD core, a gap-open penalty of 15.0 and a gap-extension penalty of 0.1 were used. The calculated sequence alignment was validated by examining alignment of the highly conserved amino acid residues, including the NLAxxD motif in TMD2, the D/ERY motif in TMD3, the CWxP motif in TMD6, and the NPxxY motif in TMD7 of GPCRs (29) .
To construct the seven TM helices and the β3-β4 hairpin structure at the N-terminal region of 2ECL for human CXCR2, the C α coordinates of the recently published x-ray crystal structure of bovine rhodopsin (PDB ID: 1U19) (30) were used as the template. The intracellular and extracellular loops (i.e., 2ECL C-terminal region, ICL3 and 3ECL) that are different in length from those of rhodopsin were constructed using the loop search tool implemented in InsightII homology module, utilizing the C α -distance matrix from a selected dataset of Brookhaven Protein Databank (PDB). The typical disulfide linkage between TMD3 and 2ECL common to most GPCRs was inserted between C119 and C196. After a short minimization, the resulting structure was subjected to a 500 ps MD simulation at 300 K, during which the transmembrane backbone atoms and the Hbonds in the 2ECL β3-β4 hairpin structure were restrained. The receptor model was sampled by extracting a snapshot of the structure every 1 ps during the simulation. The averaged structure from the last fifty 50 ps was energy minimized, with the restraints mentioned above first, then with the transmembrane backbone constraint only. Overall 3 separate simulations were repeated for the wildtype CXCR1 and CXCR2 (i.e., A V190 and B D199 ), the mutated forms (i.e., BB D199V A, B D199N and A V190D B mutants). Energy minimization and MD simulations were carried out on a Silicon Graphics Origin 350 workstation using the Consistent Force Field (CFF) (31) implemented in InsightII (Version 2005, Accelrys Inc. San Diego, CA). The cell multipole method (32) with a distance-dependent dielectric constant (ε=ε  r, with ε  = 4.0) was used for summation of non-bonding interactions.
RESULTS
Expression of CXCR1 and CXCR2 chimeric mutants in RBL-2H3 cells.
In order to determine the structural determinants involved in the rapid internalization of CXCR2 relative to CXCR1, four chimeric receptors exchanging the amino terminus (AB1 and BA1) or the region comprising the 4 th transmembrane domain (4TMD) and the 2 nd extracellular loop (2ECL) of CXCR1 for those of CXCR2 and vice versa (ABA and BAB) were stably expressed in RBL-2H3 (Fig 1, A & Table 1 ). All receptors, however, stimulated a rapid and transient increase in free intracellular Ca 2+ mobilization and phosphoinositide (PI) hydrolysis in response to both CXCL8 and CXCL1 (Fig 2, A, B&C) . Except for CXCR2, CXCL1-induced significantly lower PI hydrolysis relative to CXCL8 (Fig 2-C) . No significant difference was found in CXCL8-induced PI hydrolysis to AB1, ABA, and BA1, relative to CXCR1 and CXCR2 (3.5-4 fold over basal) (Fig 2-C) . BAB-mediated PI hydrolysis to CXCL8 was significantly lower (~2.5 fold over basal) than the WT receptors. Since BAB displayed no ligand binding properties (Table 1) , it is difficult to determine whether this difference is due to a decrease affinity of the chimeric receptor for CXCL8 or impaired ability to couple to Gi to activate PLCβ.
We next measured the rate of internalization of the chimeric receptors upon CXCL8 (100 nM) pretreatment. CXCL8 induced time-dependent internalization of all 4 receptors (Fig 2-D) . AB1 and ABA internalized as rapidly as CXCR2 (~90% after 5-10 min) whereas BA1 and BAB (~35% after 60 min) internalized far slower than CXCR1 (~55% after 60 min).
Role of the 4
th transmembrane domain (4TMD) and the 2 nd extracellular loop (2ECL) of CXCR1 and CXCR2 in receptor internalization.
To further delineate the region(s) of CXCR1 and CXCR2 involved in receptor internalization, four additional chimeras were constructed (Fig 3-A) by exchanging either the 4TMD domains (A 4TMD B and BB 4TMD A) or the 2ECL (A 2ECL B and B 2ECL A). Except for B 4TMD A, all chimeras were stably expressed in RBL-2H3 cells (Fig 3-B) and characterized. A 4TMD B and B 2ECL B
A, but not A 2ECL B, bound CXCL8 with affinities similar to the WT receptors (Fig 3-C & Table 1 ). A 4TMD B and B 2ECL A mediated intracellular Ca 2+ mobilization and PI hydrolysis in response to both CXCL8 and CXCL1 (Fig 4, A &  B) .
A 4TMD B, like CXCR1, mediated greater responses to CXCL8 whereas B 2ECL A, like CXCR2, responded to both ligands with similar potency. Upon CXCL8 pretreatment, A 4TMD B internalized as well as CXCR1 (~55% after 60 min) (Fig 4-C) . Interestingly, B 2ECL A also showed a slower time course of internalization (~50% after 60 min, Fig 4-C) .
Role of receptor glycosylation in CXCR2 internalization. CXCR1 and CXCR2 express two N-glycosylation motifs in their 2ECL (Fig 5-A , boxed motifs). Since the motifs are different between the two receptors, we constructed four chimeras in which the glycosylation sites of CXCR2 were converted to those of CXCR1 (B NNSS A and B N203D A), and vice versa (A SNVS B, A D194N B) (Fig 5-A) . The mutants were stably expressed in RBL-2H3 cells and characterized. Except for A SNVS B, all receptor variants bound CXCL1 and CXCL8 to induce intracellular Ca 2+ mobilization (Fig 5-B) . Upon CXCL8 pretreatment, BB NNSS A and B N203D A internalized like CXCR2 whereas A D194N B internalized like CXCR1 (Fig 5-C) .
Identification of specific residue of the 2 nd ECL involved in receptor internalization. In order to identify the specific residue(s) of CXCR2 involved in rapid receptor internalization relative to CXCR1, we exchanged all divergent amino acids (aa) in the 2 nd ECL of CXCR2 for their CXCR1 counterparts and, vice versa (Table II) . Except for B Y188H A, all receptors were stably expressed in RBL-2H3 cells (Table II) . The expressed receptors, except for A V190D B, bound CXCL8 to induce intracellular Ca 2+ mobilization similar to the WT receptors. We next measured receptor internalization upon exposure to CXCL8 (60 min). As shown in Figure  6 -A, the CXCR1 mutants A H179Y B, A S183V B, A L191M B and A V201L B internalized like CXCR1 (~55% after 60 min) whereas A P180S B (~40%), A V186A B (~40%) and A K197N B (~50%) were slighty more resistant to CXCL8-mediated internalization than CXCR1. All the CXCR2 mutants internalized as rapidly as CXCR2, except for B D199V A which displayed delayed internalization similar to that of CXCR1 (~55% after 60 min, Fig 6-B) .
To further determine the role of D199 in CXCR2 rapid internalization, we generated a CXCR2 mutant in which D199 was replaced for asparagine (N) (B D199N ).
B D199N was stably expressed in RBL-2H3 cells and was shown to bind CXCL8 as well as CXCR2 and B D199V A (Fig 7-A) to induce intracellular Ca 2+ mobilization and internalization (Fig 7-B & data not shown) . B D199N internalization was identical to that of CXCR2 whereas B D199V A internalized like CXCR1 (Fig 7-B) .
Role of receptor phosphorylation and dimerization in CXCL8-mediated receptor internalization. It was previously reported that phosphorylated CXCR1 migrated as a single monomeric band of ~75 kDa whereas CXCR2 showed two phosphorylated forms: a slow dimeric (~65 kDa) and a fast monomeric (~45 kDa) form (10, (33) (34) (35) Fig 8-B) . The receptors were homologously phosphorylated by CXCL8 (lanes 2) and heterologously by PMA (lanes 3). Phosphorylation by PMA (lanes 3) was less than that of CXCL8 (lanes 2). CXCR2, ABA, A 4TMD B, B 2ECL B A and B D199V A displayed two forms of phosphorylated receptors (Fig 8-A and B) . The electrophoretic mobilities of the two forms of A 4TMD B (~70 and ~50 kDa); B 2ECL A and B D199V A (~70 and ~45 kDa) were slightly different than those of CXCR2 and ABA (~65 and ~45 kDa). BB D199V A also showed a greater phosphorylation of the dimeric form (~70 kDa) than the monomeric one (~45 kDa) (Fig 8-B) . CXCR1 (Fig 8-A) and B D199N B (Fig 8-B) migrate as a single phosphorylated band (~75 kDa).
CXCR1, CXCR2, B D199V
A and B D199N mediated-ERK activation: CXCR1 and CXCR2 were shown to mediate mitogen-activated protein kinase (MAPK) activation to different extents, based on the cell lines (36) (37) (38) . In order to assess the ability of B D199V A and B D199N to activate MAPK in RBL-2H3 cells, we measured ERK1/2 phosphorylation in response to CXCL8. As shown in Figure 9 , CXCR1, CXCR2, B D199V A, and BB D199N induced time-dependent phosphorylation of ERK1/2 upon activation by CXCL8 (100 nM). Maximum response was obtained at ~5 min. CXCR1 and B D199V B A induced ERK1/2 phosphorylation to a greater extent relative to CXCR2 and BB D199N (Fig 9-B) . (14, 25, 27) . In order to determine whether B D199V A and BB D199N mediate cross-regulatory signals, RBL-2H3 stably coexpressing the RANTES (CCL5) receptor CCR5 along with B D199V A (RBL-CCR5/B D199V A), B D199N (RBL-CCR5/B D199N ), CXCR1 (RBL-CCR5/CXCR1) or CXCR2 (RBL-CCR5/CXCR2) were generated. CXCL8 and CCL5 mediated crossdesensitization of Ca mobilization was measured. As shown in Table IV (Table IV) .
2+
Computational Modeling of the 2ECLs of CXCR1, CXCR2, BB D199V A and B D199N . Multiple sequence alignment and homology models of CXCR1 and CXCR2 were constructed based on the recent x-ray structure of rhodopsin (30) . Molecular Dynamics (MD) simulations of the extracellular loop region of the WT CXCR1 and CXCR2 and the mutant forms B D199V A, B D199N and A V190D B were performed. The molecular interaction involving D199 of CXCR2 (B D199 ) was measured by the Hbond formation with the neighboring residues ( Table V) . As shown in Figure 10 -B, D199 of CXCR2 forms H-bonds with R185, T186 and R208. The H-bonding network is similar to the one between the equivalent D190 of rhodopsin and R177, Y192 and T193 (Fig 10-A) . When D199 was replaced for V (B D199V A), due to the highly hydrophobic nature of V, the neighboring polar or charged residues (R185, T186, Y188, M200, N202, and R208) could not interact with it to form the Hbonding network (Fig 10-C) . In contrast, when D199 was replaced with an N, B D199N B , H-bond could be formed with T186 and R185, but not Arg208 (Fig 10-D) . Apparently, the replacement was sufficient to regenerate the H-bonding network and stabilize the receptor in a CXCR2-like conformation thereby restoring rapid receptor internalization.
DISCUSSION
CXCL8 and its receptors CXCR1 and CXCR2 play a critical role in the pathophysiology of several inflammatory diseases including multiple sclerosis, rheumatoid arthritis and asthma. Upon activation, these receptors mediate similar as well as different cellular functions. This distinction correlates with the receptors differing kinetics of internalization and recycling upon activation by CXCL8 (10). CXCR1 internalizes slower (50-60% after 60 min) and mediates leukocyte cytotoxicity (i.e. respiratory burst) and receptor cross-regulatory signals (6, 25) . In contrast, CXCR2 internalizes rapidly (90-95% after 2-5 min) but mediates greater post-internalization signals [i.e. mitogen activated protein (MAP) kinase and protein kinase B (AKT) activation] (37).
Attempts to determine the structural determinants responsible for the different kinetics of receptor downregulation have been focusing predominantly on the intracellular domains of the receptor (13, 22) . Recent studies using tail deleted and chimeric receptors in which the tail of CXCR1 was exchanged for that of CXCR2 and, vice versa, have shown that the Cterminals are important for receptor phosphorylation, desensitization, adaptor protein binding and downregulation but not sufficient to explain the distinct kinetics of internalization of the two receptors in response to CXCL8 interaction (10) . In this study we employed a set of new This contention is based on the following observations. First, the CXCR1 derived chimera ABA which expressed the 2ECL and fourth transmembrane domain (4TMD) of CXCR2 internalized like CXCR2, ~90% in the first 5 min of activation (Fig 2-D) . Second, the CXCR2 chimera B 2ECL A which expressed the 2 nd extracellular loop of CXCR1 internalized like CXCR1 (~50% after 60 min) (Fig 4-C) . Third, the point mutant receptor BB D199V A in which aspartate 199 of the 2ECL of CXCR2 was exchanged for its valine (V) counterpart of CXCR1, showed decrease CXCL8 mediated internalization as compared to CXCR2 (~45% versus 95%, respectively, after 60 min; Fig 6-B and 7-B) .
Interestingly, when D199 was exchanged for asparagine (N) instead of valine (B D199N ), rapid internalization of CXCR2 (~90% after 5 min) was restored (Fig 7-B) . These results further suggest that D199 of the 2ECL of CXCR2 plays a critical role in stabilizing the receptor in the conformation necessary for its rapid internalization upon binding to CXCL8. Homology modeling of the 2ECL of CXCR2 based on the crystal structure of rhodopsin also supports this contention. As shown in Figure  10 -B, D199 may interact with threonine 186 (T186), arginine 185 (R185) and R208, to form an H-bonding network similar to the one formed between D190 and R177, tyrosine 192 (Y192) and T193 of rhodopsin (Fig 10-A) . When D199 was replaced for the corresponding hydrophobic valine of CXCR1, B D199V A, (Fig 10-C) no H-bond could be formed causing a conformational change in the 2ECL similar to that of CXCR1 (Fig 10-D) . In contrast, the exchange of D199 for N, BB D199N , (Fig  10-E) partially restored the H-bounding network with T186 and R185, thereby, the rapid kinetic of receptor internalization (Fig 10-D) . Despite the differences in H-bonding patterns between CXCR1 and CXCR2, it cannot be ruled out, however, that other factors may contribute to the differences in the structure and rate of internalization. These receptors interact with several adaptor proteins (i.e. arrestins, AP-2, Src, HIP) to mediate signal transduction (10, 19, 20) . It could be that conformational changes induced by D199 altered receptor/adaptor proteins complex formation and, thereby, receptor downregulation (39) .
A question addressed in this study was the role of receptor glycosylation in the distinct kinetics of CXCR1 and CXCR2 downregulation. Both receptors express two glycosylation sites with different sequence motifs within their 2ECL (Fig 5)  (16,17) .
It was previously shown that glycosylation of the CXCR2 does not affect ligand binding, signaling, or trafficking abilities (40) . Since exchanging the 2ECL of CXCR2 for that of CXCR1 (B 2ECL A) changed the rate of internalization (Fig 4-C) , this raised the possibility that CXCR1-like glycosylation could influence a change in the kinetic of internalization. However, when the glycosylation motifs of the 2ECL of CXCR2 were exchanged for those of CXCR1 (B NNSS A and B N203D A), or vice versa (A D194N B) , no significant differences were found in CXCL8 binding to both receptors or in the rates of receptor internalization, relative to the WT receptors (Fig 5-C and data not shown). These observations suggests that receptor glycosylation plays no role in receptor internalization and further indicate that Asp199 is solely responsible for the rapid internalization of CXCR2.
Receptor oligomerization has been shown to play an important role in the activation and regulation of several chemokine receptors including CCR2, CCR5, CXCR4 (41) (42) (43) (44) . To date, contrasting results exist regarding the dimerization of CXCR1 and CXCR2 and their roles in receptormediated cellular functions. Previous studies from our group and others using native and epitopetagged receptors have shown two migrating forms of CXCR2 (~40 and ~65 kDa) but one form of CXCR1 (~75 kDa) (9, 10, 33, 34) . Trettel et al (35) , recently reported that CXCR2, but not CXCR1, functions as a dimer and that could affect the kinetic of receptor downregulation. Wilson et al (45) , however, demonstrated that both CXCR1 (~45 and ~75 kDa) and CXCR2 (~40 and ~65 kDa) are capable of forming dimers. In this study, since both CXCR1 and CXCR2 internalize in a phosphorylation-dependent fashion, we used CXCL8-induced receptor phosphorylation to assess the role of receptor dimerization in receptor internalization. The data herein, clearly showed one form of CXCR1 and further suggested that receptor internalization is independent of receptor dimerization (Figs 4, 6-8) . First, the chimeras BB 2ECL A and A 4TMD B internalized like CXCR1 but displayed a slow and a fast migrating form like CXCR2 (Fig 4-C & Fig 8-B) . Second, B D199N migrated as a single slow form (~75 kDa) similar to that of CXCR1 but internalized as rapidly as CXCR2 (~90% after 5 min) (Fig 7-B & Fig 8-B) . Third, the related mutant B D199V B A showed two forms (~75 and ~45 kDa) but internalized like CXCR1(~45% after 60 min) (Fig 7-B & Fig 8-B) .
The contrast with the results reported by Wilson et al (45) is unclear. One explanation could be that native CXCR1 predominantly exists as a dimer, and CXCR2 as an equal mixture of both dimer and monomer. Thus, since dimerization of the receptor occurs in the endoplasmic reticulum (ER), it could be that overexpression of the receptors in human embryonic kidney (HEK293) cells affected the rate of dimerization resulting in two forms of CXCR1 (~75 and ~45 kDa). Against this hypothesis is that Tretell et al (35) also used the HEK293 expression system in their study. CXCR1 but not CXCR2 was shown to mediate receptor cross-regulatory signals (27) . This distinction was attributed to the length of signaling which for CXCR2 was shortened by rapid receptor internalization (14) . Indeed, the mutant BB D199V A which displayed delayed CXCL8-mediated receptor internalization, cross-desensitized CCR5-mediated intracellular Ca mobilization to CCL5 (Table IV) . In contrast, B D199N 2+ B which internalized as rapidly as CXCR2 failed to cross-desensitize responses to CCL5. B D199V A, like CXCR1, also induced a sustained ERK1/2 activation as compared to B D199N and CXCR2 (fig 9) . Sai et al (46) have recently reported that delayed internalization of the CXCR2 mutant IL/AA-CXCR2 in HL60 cells correlated with decreased ERK1/2 activation. These results are in contrast to the ones presented in this work and may well reflect differences between cell lines. Supporting this contention is that CXCR2 expressed in mouse embryonic fibroblast (MEF) cells deficient in βarrestin 1/2 -/-expression also displayed decreased receptor internalization and sustained ERK1/2, stress kinases p38 and c-Jun N-terminal protein kinase activation, relative to wild-type MEF (38) . Furthermore, several phosphorylation and internalization resistant mutants of CCR5 and the follicle-stimulating hormone receptor (FSH-R) expressed in RBL-2H3 and HEK293 cells, respectively, were also shown to induce sustained ERK1/2 activation relative to the WT receptors (47, 48) In all, the data herein provide new insights into the role of extracellular domains of the receptors in modulating signal length and ability to mediate a distinct set of cellular responses. A drawback, however, is that key chimera or point mutant such as A 2ECL B and A V190D B expressed but failed to bind or respond to ligand (Fig 3-B, Fig 4- A and Table II) . These are common limitations in studies using cellular and genetic approaches to elucidate the complexities of receptor activation and regulation. Despite these limitations, however, these studies pointed out the importance of the 2 nd extracellular loop, and more specifically Asp199, in the distinct ability of CXCR1 and CXCR2 to mediate and regulate inflammatory responses to CXCL8. As chimeras such as BAB and BA1, failed to show ligand binding, but mediated functional responses (i.e. Ca 2+ mobilization, PI hydrolysis) and underwent CXCL8-dependent internalization, the data further support the notion that distinct domains of the receptors may be involved in ligand interaction and receptor activation/regulation (17) . 1 The abbreviations used are: IL-8 or CXCL8, interleukin-8; CXCR1, IL-8 receptor A; CXCR2, IL-8 receptor B; RBL-2H3, rat basophilic leukemia-2H3; PMA, phorbol 12-myristate 13-acetate; IP, inositol phosphate; G protein, GTP-regulatory protein; FITC, fluorescein isothiocyanate, βarr, β-arrestin; ECL, extracellular loop; TMD, transmembrane domain; WT, wild-type; RIPA, radio-immunoprecipitation assay. 
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